Trial Profile
Effect of therapeutic and supratherapeutic doses of LCZ696 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2016
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Moxifloxacin
- Indications Essential hypertension; Heart failure; Hypertension; Kidney disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 26 Apr 2016 New trial record
- 16 Apr 2016 Results published in the European Journal of Clinical Pharmacology